MainStreet Investment Advisors LLC Has $823,000 Holdings in Waters Corporation $WAT

MainStreet Investment Advisors LLC lowered its position in Waters Corporation (NYSE:WAT) by 28.3% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 2,359 shares of the medical instruments supplier’s stock after selling 929 shares during the period. MainStreet Investment Advisors LLC’s holdings in Waters were worth $823,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also modified their holdings of the business. Swedbank AB grew its holdings in shares of Waters by 25.8% in the 2nd quarter. Swedbank AB now owns 40,526 shares of the medical instruments supplier’s stock valued at $14,145,000 after buying an additional 8,305 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its holdings in shares of Waters by 5.6% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 530,697 shares of the medical instruments supplier’s stock valued at $195,599,000 after purchasing an additional 28,018 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. lifted its position in Waters by 12.6% during the 2nd quarter. Mirae Asset Global Investments Co. Ltd. now owns 8,021 shares of the medical instruments supplier’s stock worth $2,800,000 after buying an additional 896 shares in the last quarter. Jacobs Levy Equity Management Inc. acquired a new position in shares of Waters during the 1st quarter worth about $1,244,000. Finally, Mn Services Vermogensbeheer B.V. grew its holdings in shares of Waters by 7.0% in the 2nd quarter. Mn Services Vermogensbeheer B.V. now owns 22,933 shares of the medical instruments supplier’s stock valued at $8,005,000 after acquiring an additional 1,500 shares in the last quarter. 94.01% of the stock is owned by institutional investors and hedge funds.

Waters Trading Down 0.3%

WAT stock opened at $378.31 on Tuesday. Waters Corporation has a one year low of $275.05 and a one year high of $423.56. The stock has a market cap of $22.52 billion, a price-to-earnings ratio of 34.11, a price-to-earnings-growth ratio of 3.19 and a beta of 1.11. The company has a fifty day moving average price of $333.23 and a two-hundred day moving average price of $327.70. The company has a debt-to-equity ratio of 0.55, a current ratio of 1.75 and a quick ratio of 1.22.

Waters (NYSE:WAT) last announced its earnings results on Thursday, May 19th. The medical instruments supplier reported $2.29 EPS for the quarter. The business had revenue of $608.55 million during the quarter. Waters had a net margin of 21.71% and a return on equity of 38.60%. Equities analysts anticipate that Waters Corporation will post 12.86 EPS for the current year.

Wall Street Analysts Forecast Growth

Several analysts recently issued reports on the company. Cowen reiterated a “hold” rating on shares of Waters in a report on Wednesday, November 5th. Redburn Partners set a $390.00 price target on Waters in a research report on Wednesday, October 8th. Jefferies Financial Group set a $385.00 price objective on Waters and gave the company a “buy” rating in a report on Monday, August 4th. Wells Fargo & Company raised their target price on shares of Waters from $315.00 to $385.00 and gave the company an “equal weight” rating in a research note on Wednesday, November 5th. Finally, Deutsche Bank Aktiengesellschaft set a $315.00 price objective on shares of Waters and gave the stock a “hold” rating in a research note on Tuesday, August 5th. Two investment analysts have rated the stock with a Strong Buy rating, six have assigned a Buy rating and nine have given a Hold rating to the company’s stock. According to MarketBeat.com, Waters presently has a consensus rating of “Moderate Buy” and a consensus target price of $381.57.

Waters Company Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.